Know what’s really happening at
Rapalogix Health before you sign on.
- On the roadmap
- Longevity Science
- Regenerative Medicine
- Aesthetic Dermatology
Rapalogix Health is a New York-based biotech startup applying regenerative medicine and longevity science to reset cellular aging in the skin. Founded in 2024 and already backed by nearly $30 million in funding, the company is positioning itself at the intersection of dermatology, aesthetic medicine, and molecular biology.
How we do it.
Most "AI market intel" is a summarized crawl of press releases. This Altis research is built from our knowledge graph of sector expert calls, synthesized with public sources.
Rapalogix Health
- Total funding raised
- ~$29.1M
- Series A round size (June 2026)
- $20M
- Year founded
- 2024
- Company size range
- 11-50
- Headquarters
- New York City, New York, United States
- Lead investor
- GordonMD Global Investments
- Customer focus
- B2B
Press reported
Altis Verified
What's in the report
Most "AI market intel" is a summarized crawl of press releases. This is what customers, competitors, and former employees actually told us.
Market Overview
Market structure, where the company sits, and growth drivers.
- market map
- Longevity Science landscape
- Longevity Science growth rate
- CAGR
Total Addressable Market
Bottom-up TAM / SAM / SOM.
- Rapalogix Health TAM
- Longevity Science market size
- market opportunity
Company Overview
What the company does and how it operates.
- what does Rapalogix Health do
- Rapalogix Health product
- business model
Product / Go-to-Market
Product, GTM motion, ICP, and who buys.
- Rapalogix Health customers
- who uses Rapalogix Health
- Rapalogix Health ICP
- go-to-market
Competitive Dynamics
The Altis Market Map and the Altis Win-Rate Index.
- Rapalogix Health competitors
- Rapalogix Health alternatives
- who competes with Rapalogix Health
- Rapalogix Health win rate
Customer Signals
Retention, satisfaction, and win/loss signals.
- Rapalogix Health reviews
- Rapalogix Health NRR
- Rapalogix Health churn
- current customers
- switching costs
Investment Debates
Investment thesis, moat, bull/bear, and key risks.
- Rapalogix Health investment thesis
- Rapalogix Health moat
- bull case bear case
- Rapalogix Health risk factors
Monetization & Financials
Business model, revenue model, and unit economics.
- Rapalogix Health ARR
- Rapalogix Health revenue
- Rapalogix Health valuation
- unit economics
Team and culture
Founders, leadership, and org.
- Rapalogix Health founders
- Rapalogix Health CEO background
- leadership team
- headcount
Trusted by
Ready to see the full picture?
This profile is based on structured company data, public funding records, and growth signal analysis tracked by Altis.